Unveiling 3 Hong Kong Dividend Stocks With Yields Up To 8.4%
In This Article:
Amidst a backdrop of mixed economic signals from global markets, including a modest uptick in Hong Kong's Hang Seng Index, investors are keenly observing opportunities for stable returns. Dividend stocks in Hong Kong offer an appealing avenue for those looking to capitalize on yields up to 8.4%, particularly as broader market conditions present both challenges and opportunities for income-focused portfolios.
Top 10 Dividend Stocks In Hong Kong
| Name | Dividend Yield | Dividend Rating |
| Chongqing Rural Commercial Bank (SEHK:3618) | 8.45% | ★★★★★★ |
| CITIC Telecom International Holdings (SEHK:1883) | 9.84% | ★★★★★★ |
| China Construction Bank (SEHK:939) | 7.53% | ★★★★★☆ |
| S.A.S. Dragon Holdings (SEHK:1184) | 8.84% | ★★★★★☆ |
| Playmates Toys (SEHK:869) | 8.96% | ★★★★★☆ |
| Bank of China (SEHK:3988) | 6.69% | ★★★★★☆ |
| China Mobile (SEHK:941) | 6.43% | ★★★★★☆ |
| Sinopharm Group (SEHK:1099) | 4.02% | ★★★★★☆ |
| International Housewares Retail (SEHK:1373) | 8.68% | ★★★★★☆ |
| Tian An China Investments (SEHK:28) | 5.13% | ★★★★★☆ |
Click here to see the full list of 90 stocks from our Top Dividend Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
JBM (Healthcare)
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: JBM (Healthcare) Limited operates as an investment holding company that manufactures, markets, distributes, and sells branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally; it has a market cap of approximately HK$0.81 billion.
Operations: JBM (Healthcare) Limited generates revenue through three primary segments: branded medicines (HK$190.11 million), health and wellness products (HK$72.19 million), and proprietary Chinese medicines (HK$386.12 million).
Dividend Yield: 8.3%
JBM (Healthcare) Limited, a dividend-paying entity in Hong Kong, recently proposed a final dividend of HK$0.0405 per share for FY 2024, underscoring its commitment to returning value to shareholders. The company's financial performance has shown significant improvement with sales rising from HK$520.32 million to HK$648.42 million and net income more than doubling from HK$57.09 million to HK$130.46 million year-over-year. This robust earnings growth supports the sustainability of its dividends, evidenced by a payout ratio of 50.8% and a cash payout ratio of 51.5%, aligning with industry norms for dividend coverage by earnings and cash flows respectively.
-
Unlock comprehensive insights into our analysis of JBM (Healthcare) stock in this dividend report.
-
Upon reviewing our latest valuation report, JBM (Healthcare)'s share price might be too pessimistic.
SINOPEC Engineering (Group)
Simply Wall St Dividend Rating: ★★★★☆☆